Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) traded down 2.7% during trading on Tuesday . The company traded as low as $1.0550 and last traded at $1.08. 26,495 shares were traded during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.11.
BioRestorative Therapies Stock Down 2.7%
The firm’s fifty day moving average is $1.40 and its two-hundred day moving average is $1.53. The firm has a market cap of $1.77 billion, a P/E ratio of -1.01 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
- What is MarketRank™? How to Use it
- Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
